PATENT CLAIM ANALYSIS

Application Number: 16045617
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "547000"]

Abstract:
The present invention relates to a composition containing a monoacetyldiglyceride compound as an active ingredient, for inhibiting blood cancer or metastasis, and a use thereof. The monoacetyldiglyceride compound according to the present invention has excellent effects of inhibiting the expression of IL-4 and inhibiting the activity of STAT-6, and thereby is capable of overcoming side effects of currently used blood cancer or metastasis inhibiting agents. Also, the monoacetyldiglyceride compound is a non-toxic compound having superior therapeutic effects and thus can be useful as a composition for preventing, treating, or improving blood cancer and metastasis.

Claim (Index 13):
The method of  claim 12 , wherein the pharmaceutical composition is formulated for oral administration.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 95.0
- Lexical Diversity: 1.87273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14912916', '15048732', '14912920', '14915799', '14936464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7737192023119958
- 35 USC 102 Novelty (BERT): 0.5496796928269864
- Combined Prediction Score: 0.7513152513634949
- Mean Citation Score: 282.91257
- Max Citation Score: 456.7374
- Similarity Product: 245.2543449588776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test